Insights from recent episode analysis
Audience Interest
Podcast Focus
Publishing Consistency
Platform Reach
Insights are generated by CastFox AI using publicly available data, episode content, and proprietary models.
Most discussed topics
Brands & references
Total monthly reach
Estimated from 16 chart positions in 16 markets.
By chart position
- 🇮🇳IN · Medicine#1541K to 10K
- 🇭🇰HK · Medicine#2210K to 30K
- 🇮🇱IL · Medicine#3110K to 30K
- 🇨🇱CL · Medicine#3610K to 30K
- 🇰🇪KE · Medicine#523K to 10K
- Per-Episode Audience
Est. listeners per new episode within ~30 days
14K to 49K🎙 Daily cadence·229 episodes·Last published yesterday - Monthly Reach
Unique listeners across all episodes (30 days)
47K to 164K🇭🇰18%🇮🇱18%🇨🇱18%+13 more - Active Followers
Loyal subscribers who consistently listen
19K to 66K
Market Insights
Platform Distribution
Reach across major podcast platforms, updated hourly
Total Followers
—
Total Plays
—
Total Reviews
—
* Data sourced directly from platform APIs and aggregated hourly across all major podcast directories.
On the show
From 13 epsHosts
Recent guests
Recent episodes
Berlin Masterclass | Advanced prostate cancer
Jun 29, 2026
32m 53s
EV-pembro in localised and advanced bladder cancer - a superb summary!
Jun 24, 2026
32m 44s
Testis cancer and miR-371 - all you need to know!
Jun 20, 2026
24m 53s
Journal club #8 | PROTECT and EV-301
Jun 13, 2026
22m 35s
Bayer Apex comes to Melbourne!
Jun 9, 2026
25m 49s
Social Links & Contact
Official channels & resources
Official Website
Login
RSS Feed
Login
| Date | Episode | Topics | Guests | Brands | Places | Keywords | Sponsor | Length | |
|---|---|---|---|---|---|---|---|---|---|
| 6/29/26 | Berlin Masterclass | Advanced prostate cancer | Hot topics in a hot city!! Declan and Renu escaped from deep Winter in Melbourne and landed into the hottest day on record in Berlin!! We are here to help with the Astellas Global Prostate Cancer Masterclass, a wonderful two day meeting focussing on advanced prostate cancer. Delegates from all over the world and a top class local and International faculty. We catch up with great friends of GU Cast Stephen Freedland (Cedars-Sinai Medical Centre, Los Angeles) and Bertrand Tombal (UC Louvain, Br... | 32m 53s | ||||||
| 6/24/26 | EV-pembro in localised and advanced bladder cancer - a superb summary! | All you need to know about enfortumab vedotin (EV) & pembro in bladder cancer in 25 minutes! We are joined in studio by bladder cancer gurus Shilpa Gupta (Cleveland Clinic, USA) and Andrew Weickhardt (Austin Health, AUS) to get an update on the role of EV-pembro in both muscle-invasive localised bladder cancer, and metastatic bladder cancer. Shilpa led a very nice paper in this month's European Urology titled optimal management of muscle, invasive bladder, cancer, so we were very keen to ... | 32m 44s | ||||||
| 6/20/26 | Testis cancer and miR-371 - all you need to know! | Yep it's been a buzz word in testis cancer for a while now, but with the read-out of the CLIMATE and SWOG 1823 trials in the past six months, we thought we better get ourselves updated on this exciting biomarker. We are joined in studio by testis cancer gurus Ben Tran (Medical Oncologist, Peter MacCallum Cancer Centre, Melbourne), and online by Aditya Bagrodia (Urologist, UCSD, San Diego), to give us a bluffers guide to miR-371. Plus we hear about the fantastic MaGIC Consortium global testi... | 24m 53s | ||||||
| 6/13/26 | Journal club #8 | PROTECT and EV-301 | Welcome to Episode 8 of our monthly GU Cast Journal Club! Today we focus on two very important papers in localised prostate cancer and metastatic bladder cancer. The landmark 15 year update of the PROTECT trial, published in NEJM in 2023, and the breakthrough EV-301 trial which heralded enfortumab vedotin in progressive metastatic bladder cancer, published in NEJM in 2021. We are delighted to welcome back our GU Cast Journal Club Editors, Dr Carlos Delgado (Mexico City, MEX), and Dr Elena Be... | 22m 35s | ||||||
| 6/9/26 | Bayer Apex comes to Melbourne!✨ | prostate cancermedical conference+4 | — | Bayer Apex | MelbourneAsia-Pacific | Bayer ApexMelbourne+5 | — | 25m 49s | |
| 5/31/26 | Did PROTEUS just change Urology??✨ | prostate cancersurgery+4 | Dr Mary-Ellen Taplin | Dana Farber Cancer InstituteHarvard University+1 | — | PROTEUS trialprostate cancer+5 | — | 39m 20s | |
| 5/17/26 | ARASEC and Lead-in ADT - China focus✨ | ARASEC triallead-in ADT+5 | — | GU Cast ChinaAUA+1 | — | ARASEC triallead-in ADT+5 | — | 32m 28s | |
| 4/23/26 | Is Copper the new Gold??! Co-PSMA trial in European Urology✨ | PSMA tracerbiochemical recurrence+3 | Professor Louise EmmettDr Matt Roberts | 64Cu-SAR-bisPSMA68Ga-PSMA-11+2 | — | PSMA tracerbiochemical recurrence+3 | — | 27m 25s | |
| 4/12/26 | EAU Prostate Cancer Guideline Update✨ | prostate cancerguideline updates+3 | Derya TilkiGianluca Giannarini | EAU Guideline CommitteeEAU Guideline Office | Melbourne | EAU Prostate Cancer GuidelineDerya Tilki+3 | — | 28m 37s | |
| 4/6/26 | Journal club #7 | proPSMA and Penile Fractures(!)✨ | prostate cancerPSMA PET/CT+3 | — | LancetBJUI | London | proPSMAPSMA PET/CT+6 | — | 28m 09s | |
Want analysis for the episodes below?Free for Pro Submit a request, we'll have your selected episodes analyzed within an hour. Free, at no cost to you, for Pro users. | |||||||||
| 4/2/26 | ASPIRE-ing to answer the Triplet question! With Rana McKay and Deepak Kilari✨ | clinical trialsoncology+4 | Rana McKayDeepak Kilari | Alliance for Clinical Trials in OncologyADT+3 | — | ASPIRE trialADT+5 | — | 25m 11s | |
| 3/20/26 |  From Studio to Stage: GU Cast Live at EAU in London!✨ | live showurology+3 | — | EAU Scientific OfficeMediAVentures | London | urologylive podcast+3 | — | 41m 13s | |
| 3/13/26 | PRIMARY 2 is positive! PSMA PET/CT moves to early detection✨ | prostate cancerearly detection+3 | Dr James Buteau | Peter MacCallum Cancer CentreLancet Oncology | London | PRIMARY 2PSMA PET/CT+5 | — | 33m 44s | |
| 3/8/26 | Histolog digital microscopy | All you need to know!✨ | intra-operative margin assessmentprostate cancer surgery+3 | — | ORSI AcademySamantree Medical | — | intra-operative margin assessmentprostate cancer+4 | — | 38m 01s | |
| 3/6/26 | Win a trip to the APCCC in Lugano!!!✨ | prostate cancergiveaway+3 | — | APCCCEAU+2 | Lugano | APCCCLugano+3 | — | 1m 40s | |
| 2/28/26 | Journal Club #6 | POUT and SEMS✨ | urothelial cancertesticular cancer+3 | Dr Carlos DelgadoDr Elena Berg | POUT trialSEMS trial+4 | — | POUT trialSEMS trial+4 | — | 26m 24s | |
| 2/26/26 | ARPIs, SPARC and Organised Prostate Testing | With Anders Bjartell✨ | prostate cancerADT/ARPI doublets+4 | Anders Bjartell | Lund UniversityUniversity Hospital Malmo+1 | — | prostate cancerADT+5 | — | 40m 58s | |
| 2/24/26 | Periop EV-Pembro | Do we even need cystectomy anymore?? EV-303 with Christof Vulsteke | Giant bladder cancer paper in NEJM this week with the highly anticipated results of the perioperative EV-Pembro trial (EV-303 / KN-905). Already we can say this is a landmark publicaion in bladder cancer that will change practice and even challenge the role of cystectomy (maybe)! Declan Murphy and Renu Eapen caught up with first author Christof Vulsteke (Integrated Cancer Centre, Ghent, BEL) when we were at ESMO Asia recently and had a chat about this work and how it will change practic... | 20m 46s | ||||||
| 2/22/26 | Neha and Amar on what really matters | Following on from last week's episode on "toxicity", we are delighted today to welcome back two great friends of GU Cast from the world of radiation oncology - ASTRO President Dr Neha Vapiwala (University of Pennsylvania), and European Urology Associate Editor, Dr Amar Kishan (University of California, Los Angeles). We go through Amar and Neha's letter to the editor following the recent paper in Eur Urol Oncol from the IRRADIATE registry, and dive into the opportunities we have working ... | 30m 43s | ||||||
| 2/8/26 | GU Toxicity, AI Toxicity & Twitter toxicity!!! | In case you missed it, or you've already abandoned Twitter (memo to self - must do that ourselves!), we witnessed some pretty toxic stuff over there in the past couple of weeks. Vile personal attacks, calls for resignations, accusations of nefarious behaviour etc etc, mostly triggered by an AI-generated infographic attempting to illustarte a recent paper in European Urology Oncology. We chat with first author Dr Riccardo Bertolo (University of Verona, ITA), about his first-hand experien... | 38m 22s | ||||||
| 1/9/26 | Journal Club #5 | Lamm BCG maintenance and CHAARTED | Happy New Year and welcome to Episode 5 of our monthly GU Cast Journal Club! Today we focus on two classic papers in non-invasive bladder cancer and metastatic prostate cancer. The Lamm RCT of maintenance BCG is a landmark trial for all sorts of reasons, published in J Urol in 2000. And the CHAARTED paper of chemohormonal therapy is the landmark trial of combination therapy in mHSPC, published in NEJM in 2015. We are delighted to welcome back our GU Cast Journal Club Editors, Dr Carlos Delga... | 30m 52s | ||||||
| 12/4/25 | Focus on China | ESMO prostate cancer highlights | Another of our special Themed Podcasts focussed on prostate cancer in China, supported by our Gold Partner, Bayer. We are joined as ever by our China Editor, Dr Yao Zhu (Fudan University Shanghai Cancer Centre), and also special guest Dr Yige Bao (SCU Xiamen Hospital). Not only do we learn about pandas in West China, but also some great highlights from the recent ESMO Annual Meeting in Berlin! Hosted as ever by Dr Renu Eapen and Prof Declan Murphy Even better on our YouTube channel | 40m 08s | ||||||
| 11/30/25 |  Journal Club #4 | PRECISION and EB-StaR | Episode 4 of our monthly GU Cast Journal Club and today we focus on two important papers in prostate cancer diagnostics and bladder cancer surgery. The PRECISION NEJM paper 2018 is a landmark publication which defined the role of mpMRI in early detection, and changed practice in many countries. The EB-StaR trial should also change practice after its European Urology 2024 publication, but has it??! We are delighted to welcome back our GU Cast Journal Club Editors, Dr Carlos Delgado (Melbourne... | 32m 27s | ||||||
| 11/28/25 | Let's Visit the ORSI Academy! World class robotic surgery training facility | An exclusive behind-the-scenes look at the world-famous ORSI Academy in Belgium! Declan and Renu travelled to this remarkable facility just outside Ghent in Belgium, jammed full of tens of millions of dollars worth of robotic surgery technology from the world's top providers - Intuitive Surgical, Medtronic, Microport and more. Every day, surgeons from all around the world are getting hands-on experience using the latest robotic surgery technology in an array of training environments. Plus ORS... | 47m 18s | ||||||
| 11/27/25 | Sexual health following prostate cancer treatment | With Chris Nelson | World-renowned sexual health expert, Dr Chris Nelson, Chief of Psychology at Memorial Sloan-Kettering Cancer Centre, joins us in studio to run through the new Movember-supported "Guidelines for Sexual Health Care for Prostate Cancer Patients". A really helpful overview and structure for anyone working in this field, and for patients and their loved ones. Chris shares his 20-plus years of experience working in this field at one of the world's premier prostate cancer centres. Even better on o... | 32m 54s | ||||||
Showing 25 of 237
Pitch Fit is a Pro feature
See how bookable this show is for guests, which brands already advertise, the per-episode ad value, and the best-fit guest and sponsor profile. The numbers are blurred on the free plan.
How readily this show books outside guests like you.
How proven this show is for host-read sponsorships.
For Guests
ProFor Advertisers
ProUpgrade to Pro to unlock guest cadence, sponsor categories, fit scores, and per-episode ad value for this show.
Chart Positions
18 placements across 16 markets.
Chart Positions
18 placements across 16 markets.